Daily Roundup
Thursday, 2nd July 2026
Last updated: 14:00 | Max Version 🚀
SPZ.ASX IMB.ASX TLX.ASX EOS.ASX IPX.ASX
Smart Parking is making a strategic push into the US market with its USD$12 million acquisition of American Parking. The deal brings 54 locations across Oklahoma, Texas, and Arkansas into the fold, expanding SPZ's total US footprint to over 200 sites. American Parking generated USD$8.0 million in revenues and USD$1.4 million in EBITDA last year, and the acquisition is expected to be earnings accretive right out of the gate. The company funded the deal using existing cash reserves, its debt facility, and shares, signaling confidence in the growth trajectory ahead.
Intelligent Monitoring Group is making a much bigger splash across the Atlantic. The company has entered into a binding agreement to acquire ADT's UK residential security business for GBP £180 million, a transformational deal that's set to close in the first half of 2027. This isn't just incremental growth—IMG will add GBP £12.5 million per month in recurring revenue from over 160,000 direct customers, and the acquisition is expected to increase pro forma annualised EBITDA by approximately 300% to A$130 million. The company is funding the transaction through a new debt facility and vendor equity placement, with no additional external equity required beyond the consideration shares. At current exchange rates, IMG expects the deal to boost pro forma EPS to 9.0 cents per share, making it materially earnings accretive.
Telix Pharmaceuticals is advancing its cancer treatment program after securing FDA alignment on the ProstACT Global Phase 3 trial. The FDA has confirmed the safety data from Part 1 and approved the clinical protocol and statistical framework for Part 2, which will test TLX591-Tx in metastatic castration-resistant prostate cancer. The trial is currently recruiting approximately 490 patients across approved jurisdictions including Australia, New Zealand, Canada, Türkiye, the UK, China, Singapore, and South Korea.
Electro Optic Systems has landed new sales orders worth approximately A$38 million. The company secured a US$16 million (~A$23m) contract for its Naval R400 Remote Weapon System from a new Middle East customer, with deliveries spanning seven years. Meanwhile, EOS's MARSS division picked up an £8 million (~A$15m) order for a counter-drone command and training centre from an existing Middle East customer, with most of the work expected to be completed during 2026 and 2027.
IperionX has completed its acquisition of the Camden critical minerals assets in Tennessee, unlocking a significant advantage in the race to secure US-based rare earth and titanium supplies. The deal delivers ultra-high-grade surface stockpiles with grades 5 to 10 times higher than what's available at IperionX's adjacent Titan Project. The historical silica sand operations at Camden have already pre-processed these minerals into accessible stockpiles, potentially slashing capital intensity and mining costs. Pre-stripped Lower McNairy mineralization offers rapid access to high-grade seams, and established infrastructure on site could reduce development risk and capital expenditure. IperionX is accelerating drilling and metallurgical testing, with a formal mineral resource estimate expected by the end of 2026.
References
| SPZ.ASX | 08:19 | 78 American Parking Acquisition |
| IMB.ASX | 08:54 | 70 IMG UK Acquisition |
| TLX.ASX | 10:07 | 69 FDA Alignment to Advance ProstACT Global Phase 3 Trial |
| EOS.ASX | 08:40 | 69 New Sales Orders (A$38m) |
| IPX.ASX | 09:19 | 68 Acquisition Delivers High Value Critical Minerals |
| IMB.ASX | 08:54 | 60 IMB Project Amsterdam Investor Presentation |